Belpointe Asset Management LLC Bio Techne Corp Transaction History

Belpointe Asset Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$71.62 - $86.62 $16,687 - $20,182	233 Added 34.26%	913 $67,000
Q4 2022 Feb 08, 2023	BUY	$80.67 - $352.29 $54,855 - $239,557	680 New	680 $56,000
Q2 2022 Aug 02, 2022	SELL	$322.67 - $449.65 $180,372 - $251,354	-559 Closed	0 $0
Q1 2022 Apr 28, 2022	SELL	$353.85 - $487.79 $52,723 - $72,680	-149 Reduced 21.05%	559 $242,000
Q4 2021 Feb 15, 2022	BUY	$456.15 - $525.06 $48,351 - $55,656	106 Added 17.61%	708 $366,000
Q3 2021 Nov 15, 2021	BUY	$444.87 - $538.88 $102,320 - $123,942	230 Added 61.83%	602 $292,000
Q2 2021 Aug 09, 2021	BUY	$387.35 - $450.26 $144,094 - $167,496	372 New	372 $167,000

602

151M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.84B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Belpointe Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Belpointe Asset Management LLC with notifications on news.